Role of circulating tumor cells in future diagnosis and therapy of cancer

Abstract

Circulating tumor cells (CTCs) have become a blistering topic of discussion for oncologists because of their tremendous potential in the diagnosis and treatment of cancer. Over the past few years, they have been doled with quite an amount of research in this area understanding that CTCs are shed from tumors and circulate in the bloodstream. This process can also occur at an early stage of cancer. The major limitation in isolation of CTCs is their availability in limited numbers. Hence, many techniques have been developed and are under continuous improvement to enhance their efficacy of CTC isolation and enumeration. They have shown their potentiality to not just indicate the presence of a tumor but also to provide us with its core information. They have also proven to be useful in detecting minor subgroups of cells present in the primary tissue which might eventually be the cause of treatment resistance or relapse of the disease. Hence, detecting and characterizing CTCs can definitely become an inevitable step in treating solid tumor malignancies. In this review, we have tried to comprehend the basics of CTCs including isolation, detection, characterization, and molecular mechanism of their circulation in the blood stream. We have mostly focused on the significance of CTCs in diagnosis and therapies of four most common types of cancers, namely, breast, prostate, lung, and colorectal. This review provides the coverage of most of the advancements with regards to different tumor malignancies and their probable use in predicting outcomes of the disease to realize the concept of personalized medicine.

Keywords

Cancer stem cells / circulating tumor cells / epithelial to mesenchymal transition / metastasis / molecular markers / personalized medicine

References

[1] Gavhane YN,Bhagat AK,Bhong KK,Yadav AV.Solid tumors: facts, challenges and solutions..Int J Pharm Sci Res2011;2:1-12

[2] Bedard PL,Ratain MJ.Tumorheterogeneity in the clinic..Nature2013;501:355-64 PMCID:PMC5224525

[3] Greaves M.Clonal evolution in cancer..Nature2012;481:306-13 PMCID:PMC3367003

[4] Holohan C,Longley DB.Cancer drug resistance: an evolving paradigm..Nat Rev Cancer2013;13:714-26

[5] Bogenrieder T.Axis of evil: Molecular mechanisms of cancer metastasis..Oncogene2003;22:6524-36

[6] Kleiner DE.Matrix metalloproteinases and metastasis..Cancer Chemother Pharmacol1999;43 Suppl:S42-51

[7] Chaffer CL.A perspective on cancer cell metastasis..Science2011;331:1559-64

[8] Micalizzi DS,Ford HL.Epithelial-mesenchymal transition in cancer: parallels between normal development and tumour progression..J Mammary Gland Biol Neoplasia2010;15:117-34 PMCID:PMC2886089

[9] Carmeliet P.Angiogenesis in cancer and other diseases..Nature2000;407:249-57

[10] Yap TA,Omlin A,de Bono JS.Circulating tumour cells: a multifunctional biomarker..Clin Cancer Res2014;20:2553-68

[11] Plaks V,Werb Z.Cancer. Circulating tumour cells..Science2013;341:1186-8 PMCID:PMC3842225

[12] Nakaya Y.EMT in developmental morphogenesis..Cancer Lett2013;341:9-15

[13] de Wit S,Terstappen LW.Detection of circulating tumour cells..Scientifica (Cairo)2014;2014:819362

[14] Krebs MG,Carter L,Blackhall FH.Molecular analysis of circulating tumour cells-biology and biomarkers..Nat Rev Clin Oncol2014;11:129-44

[15] Krebs MG,Ward TH,Dive C.Circulating tumour cells: their utility in cancer management and predicting outcomes..Ther Adv Med Oncol2010;2:351-65 PMCID:PMC3126032

[16] King JD,Lang JM.Rapid translation of circulating tumour cell biomarkers into clinical practice: technology developmet, clinical needs and regulatory requirements..Lab Chip2014;14:24-31

[17] Balic M,Lin H.Cancer metastasis: advances in the detection and characterization of disseminated tumour cells facilitate clinical translation..Natl Med J India2005;18:250-5

[18] Riethdorf S,Zhang L,Loibl S,Roller M,Fehm T,Hilfrich J,Tesch H,Untch M,Pantel K.Detection and HER2 expression of circulating tumour cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial..Clin Cancer Res2010;16:2634-45

[19] Singh A.EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer..Oncogene2010;29:4741-51 PMCID:PMC3176718

[20] Nesteruk D,Fabisiewicz S,Siedlecki JA.Evaluation of prognostic significance of circulating tumor cells detection in rectal cancer patients treated with preoperative radiotherapy: prospectively collected material data..Biomed Res Int2014;2014:712827 PMCID:PMC4070579

[21] Alix-Panabières C.Technologies for detection of circulating tumour cells: facts and vision..Lab Chip2014;14:57-62

[22] Gertler R,Fuehrer K,Nekarda H.Detection of circulating tumor cells in blood using an optimized density gradient centrifugation..Recent Results Cancer Res2003;162:149-55

[23] Lustberg M,Zborowski M.Emerging technologies for CTC detection based on depletion of normal cells..Recent Results Cancer Res2012;195:97-110 PMCID:PMC3775349

[24] Gerges N,Jabado N.New technologies for the detection of circulating tumour cells..Br Med Bull2010;94:49-64

[25] Sun YF,Zhou J,Fan J Xu Y.Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance..J Cancer Res Clin Oncol2011;137:1151-73

[26] Yu M,Toner M,Haber DA.Circulating tumor cells: approaches to isolation and characterization..J Cell Biol2011;192:373-82 PMCID:PMC3101098

[27] Chen P,Hoshino K.Multiscale immunomagnetic enrichment of circulating tumour cells: from tubes to microchips..Lab Chip2014;14:446-58

[28] Karabacak NM,Fachin F,Pai V,Martel JM,Smith K,Yang J,Morgan B,Barber TA,Maheswaran S,Haber DA.Microfluidic, marker-free isolation of circulating tumour cells from blood samples..Nat Protoc2014;9:694-710 PMCID:PMC4179254

[29] Jackson JM,Hupert ML,Pullagurla S,Aufforth RD,Torphy RJ,Soper SA.UV activation of polymeric high ascpect ratio microstructures: ramifications in antibody surface loading for circulating tumour cell..Lab Chip2014;14:106-17 PMCID:PMC4182936

[30] Weltin A,Kieninger J,Jobst G,Ehret R.Cell culture monitoring for drug screening and cancer research: a transparent, microfluidic, multi-sensor microsystem..Lab Chip2014;14:138-46

[31] Hyun KA.Advances and critical concerns with the microfluidic enrichments of circulating tumour cells..Lab Chip2014;14:45-56

[32] Vona G,Louha M,Romana S,Capron F,Pazzagli M,Lacour B,Paterlini-Bréchot P.Isolation by size of epithelial tumor cells..Am J Pathol2000;156:57-63

[33] Peeters DJ,Van den Eynden GG,Rothé F,Sieuwerts AM,Rutten A,Pauwels P,Vermeulen PB.Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting..Br J Cancer2013;108:1358-67 PMCID:PMC3619252

[34] Lu YT,Shen Q,Wu D,Song M,Ouyang WH,Lichterman J,Xuan X,Chung LW,Tseng HR,Posadas EM.NanoVelcro Chip for CTC enumeration in prostate cancer patients..Methods2013;64:144-52 PMCID:PMC3834112

[35] Kolostova K,Hoffman RM.In vitro culture and characterization of human lung cancer circulating tumor cells isolated by size exclusion from an orthotopic nude-mouse model expressing fluorescent protein..J Fluoresc2014;24:1531-6 PMCID:PMC4159578

[36] Ju M,Simone CB,Xu XS,Xu W,Hahn SM,Karakousis G."Capturing the elusive foe": a novel telomerase promoter-based approach to detect melanoma circulating tumour cells..Cancer Res2014;74:1871

[37] Casavant BP,Berry SM,Lang JM.The VerIFAST: an integrated method for cell isolation and extracellular/intracellular staining..Lap Chip2013;13:391-6

[38] Jin C,Duffy SP,Tavassoli P,Ma H.Technologies for label-free separation of circulating tumour cells: from historical foundations to recent developments..Lab Chip2014;14:32-44

[39] Krawczyk N,Banys M,Ruckhaeberle E.Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells of Breast Cancer Patients..Biomed Res Int2014;2014:415721 PMCID:PMC4034492

[40] Khan MA,Zhang D.Twist: a molecular target in cancer therapeutics..Tumor Biol2013;34:2497-506

[41] Alonso-Alconada L,Madissoo K,Krakstad C,Wik E,Coenegrachts L,Gil-Moreno A,Cueva J,Ortega E,Colas E,Cusido M,Nijman HW,Green JA,Reventos J,Salvesen HB,Matias-Guiu X,Abal M1.Molecular profiling of circulating tumour cells links plasticity to the metastatic process in endometrial cancer..Mol Cancer2014;13:223 PMCID:PMC4190574

[42] Nagrath S,Maheswaran S,Irimia D,Smith MR,Digumarthy S,Ryan P,Tompkins RG,Toner M.Isolation of rare circulating tumour cells in cancer patients by microchip technology..Nature2007;450:1235-9 PMCID:PMC3090667

[43] Chen CL,Mahalingum D,Jadhav RR,Wang CM.Epithelial-to-mesenchymal markers of circulating tumour cells for detection of castration-resistant prostate cancer..Cancer Res2014;74:5588

[44] Galletti G,Vahdat LT,Santana SM,Kirby BJ.Isolation of breast cancer and gastric circulating tumour cells by use of an anti HER2-based microfluidic device..Lab Chip2014;14:147-56 PMCID:PMC3921117

[45] Armstrong AJ,Oltean S,Bitting RL,Herold CI,George DJ.Circulating tumour cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers..Mol Cancer Res2011;9:997-1007 PMCID:PMC3157566

[46] Smirnov DA,Foulk BW,Doyle GV,Meropol NJ,Cohen SJ,Connelly MC,O'Hara SM.Global gene expression profiling of circulating tumour cells..Cancer Res2005;65:4993-7

[47] Williams A,Ao Z,Toress-Munoz J,Pelley R,Borden E,Datar R,Cote R.Capture and molecular characterization of CTC in metastatic breast, prostate, colorectal and renal cancer..Cancer Res2012;72:2372

[48] Haber DA,Sequist L,Ozkummur E,Miyamoto D,Shah A,Stott S.Molecular characterization of circulating tumour cells..Mol Cancer Ther2013;12:PL06-04. (Abstract)

[49] Schölch S,Rahbari NN,Swiersy A,Weitz J.Circulating tumor cells of colorectal cancer..Cancer Cell Microenviron2014;1:e323

[50] Aceto N,Miyamoto DT,Wittner BS,Yu M,Engstrom A,Brannigan BW,Stott SL,Ramaswamy S,Lin CP,Haber DA.Circulating tumour cell clusters are oligoclonal precursors of breast cancer metastasis..Cell2014;158:1110-22 PMCID:PMC4149753

[51] Bidard FC,Sigal-Zafrani B,Mathiot C,Thiery JP,Pierga JY.Prognosis of women with stage IV breast cancer depends on detection of circulating tumour cells rather than disseminated tumour cells..Ann Oncol2008;19:496-500

[52] Rack B,Jückstock J,Hepp P,Friedl TW,Tesch H,Fehm T,Lichtenegger W,Friese K,Janni W.Circulating tumor cells predict survival in early average-to-high risk breast cancer patients..J Natl Cancer Inst2014;106:dju066

[53] Lianidou ES.Ciculating tumour cells in breast cancer: Detection systems, molecular characterization, and future challenges..Clin Chem2011;57:1242-55

[54] Fernandez SV,Fittipaldi P,Palazzo J,Alpaugh K.TP53 mutations detected in circulating tumour cells present in the blood of metastatic triple negative breast cancer patients..Breast Cancer Res2014;16:445 PMCID:PMC4303125

[55] Swaby RF.Circulating tumor cells in breast cancer: a tool whose time has come of age..BMC Med2011;9:43 PMCID:PMC3107794

[56] Obermayr E,Tea MM,Krainer M.Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients..BMC Cancer2010;10:666 PMCID:PMC3013085

[57] Polzer B,Pasch S,Zorzino L,Andergassen U,Czyz ZT,Treitschke S,Sergio M,Doffini A,Calanca A,Bolognesi C,Fasching PA,Rack B,Giorgini G,Klein CA.Molecular profiling of single circulating tumor cells with diagnostic intention..EMBO Mol Med2014;6:1371-86 PMCID:PMC4237466

[58] Bredemeier M,Kimmig R.Establishment of a multimarker gene panel for the characterization of circulating tumor cells in metastatic breast cancer..Cancer Res2013;73:1466

[59] Mirantes C,Ferrer I,Prat J.Epithelial-tomesenchymal transition and stem cells in endometrial cancer..Hum Pathol2013;44:1973-81

[60] Wik E,Krakstad C,Birkeland E,Mjos S,Mannelqvist M,Oyan AM,Akslen LA.Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma..Clin Cancer Res2013;19:1094-105

[61] Powell AA,Zhang H,Reddy A,Telli ML,Carlson RW,Sheth S,Ford JM,Quake SR,Mindrinos MN,Dairkee SH,Jeffrey SS.Single cell profiling of circulating tumour cells: transcriptional heterogeneity and diversity from breast cancer cell lines..PLoS One2012;7:e33788

[62] Königsberg R,Bises G,Gneist M,de Santis M,Hudec M.Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients..Acta Oncol2011;50:700-10

[63] Brugger W,Glatt M,Mertelsmann R.Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumor..Blood1994;83:636-40

[64] Peeters DJ,Van den Eynden GG,Wuyts H,Peeters M,Van Laere SJ,Vermeulen PB.Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes..Br J Cancer2014;110:375-83 PMCID:PMC3899770

[65] Smerage JB,Hortobagyi GN,Leyland-Jones B,Tejwani S,O'Rourke MA,Doyle GV,Livingston RB.Circulating Tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500..J Clin Oncol2014;256:251

[66] Martelotto LG,Piscuoglio S,Reis-Filho JS.Breast cancer intra-tumor heterogeneity..Breast Cancer Res2014;16:210 PMCID:PMC4053234

[67] Dittamore R,Krupa R,Danila DC,Bales N,Scher HI.Molecular characteriszation of circulating tumour cells (CTC) and CTC subpopulations in baseline and progressive metastatic castration resistant prostate cancer (mCRPC)..J Clin Oncol2014;32:abstr e16018

[68] Hoogland AM,van Leenders GJ.Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a review..Biomed Res Int2014;2014:341324 PMCID:PMC4163394

[69] Miyamoto DT,Stott SL,Wittner BS,Smas ME,Brannigan BW,Bander NH,Sequist LV,Ramaswamy S,Maheswaran S.Androgen receptor signalling in circulating tumor cells as a marker of hormonally responsive prostate cancer..Cancer Discov2012;2:995-1003 PMCID:PMC3508523

[70] Attard G,Olmos D,Vickers E,Levink R,Moreira J,Oommen NB,Jameson C,Sipkema R,Parker C,Kaye SB,Molina A,Terstappen LW.Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer..Cancer Res2009;69:2912-8

[71] Giesing M,Driesel G.Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy..BJU Int2010;105:1000-10

[72] Hu B,Goldkorn A.Circulating tumor cells in prostate cancer..Cancers2013;5:1676-90 PMCID:PMC3875960

[73] de Bono JS,Montgomery RB,Miller MC,Doyle GV,Pienta KJ.Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer..Clin Cancer Res2008;14:6302-9

[74] Scher HI,Higano CS,Taplin ME,Rathkopf D,Yu EY,Hung D,Seely L,Danila DC,Larson S,Sawyers CL.Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study..Lancet2010;375:1437-46

[75] Moreno JG,Gross S,Gomella LG.Circulating tumor cells predict survival in patients with metastatic prostate cancer..Urology2005;65:713-8

[76] Shaffer DR,Danila DC,Gonzalez-Espinoza R,Anand A,Maslak P,Terstappen LW,Heller G,Scher HI.Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer..Clin Cancer Res2007;13:2023-9

[77] Leversha MA,Asgari Z,Lin O,Anand A,Heller G,Scher HI.Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer..Clin Cancer Res2009;15:2091-7 PMCID:PMC2875199

[78] Danila DC,Scher HI.Circulating tumor cells as biomarkers in prostate cancer..Clin Cancer Res2011;17:3903-12 PMCID:PMC3743247

[79] Danila DC,Gignac GA,Anand A,Lilja H,Larson S,Scher HI.Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer..Clin Cancer Res2007;13:7053-8

[80] Olmos D,Ang JE,Attard G,Reid AH,Fong PC,Molife R,Parker C,de Bono JS.Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience..Ann Oncol2009;20:27-33

[81] Galletti G,Tagawa ST,Giannakakou P.Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential..Mol Diagn Ther2014;18:389-402 PMCID:PMC4149177

[82] Romiti A,Di Rocco R,Milano A,Leone L,Mazzetta F,Sarcina I,D'Antonio C,Ferri M,Marchetti P.Circulating tumor cells count predicts survival in colorectal cancer patients..J Gastrointestin Liver Dis2014;23:279-84

[83] van Dalum G,Scholten LF,Vermes I,De Groot MR.Importance of circulating tumor cells in newly diagnosed colorectal cancer..Int J Oncol2015;46:1361-8

[84] Barbazán J,Muinelo-Romay L,Abalo A,Candamio S,Fernández B,de Los ángeles Casares M,López-López R.Molecular characterization of circulating tumor cells in human metastatic colorectal cancer..PLoS One2012;7:e40476

[85] Loveday RL,Beral D,Monson JR.Telomerase activity in circulating colorectal tumour cells..Cancer Ther2004;2:115-20

[86] Molnar B,Tanko L,Tulassay Z.Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients..Clin Cancer Res2001;7:4080-5

[87] Bork U,Schölch S,Kahlert C,Weitz J.Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study..Br J Cancer2014;112:1306-13 PMCID:PMC4402459

[88] de Albuquerque A,Stölzel U,Boese-Landgraf J,Stamminger G,Kaul S.Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients..J Transl Med2012;10:222 PMCID:PMC3508882

[89] Allen JE,Kunkel M,Das A,Joudeh J,El-Deiry WS.Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs..Oncotarget2014;5:1753-60 PMCID:PMC4039127

[90] Denève E,Ramos J,Coffy A,Maudelonde T,Pantel K.Capture of viable circulating tumor cells in the liver of colorectal cancer patients..Clin Chem2013;59:1384-92

[91] Antolovic D,Carstens A,Büchler MW,Koch M.Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies..BMC Biotechnol2010;10:35 PMCID:PMC2868015

[92] Taenzer A,Wikman H.Circulating tumor-derived biomarkers in lung cancer..J Thorac Dis2012;4:448-9

[93] Casavant BP,Tokar JJ,Traynor AM,Lang JM.Paired diagnostic and pharmacodynamic analysis of rare non-small cells lung cancer cells enabled by the VerIFAST platform..Lab Chip2014;14:99-105 PMCID:PMC3897162

[94] Zhang MH,Zhao S,Yang MP.Circulating tumor cells in lung cancer: Detection methods and clinical impact..Chin German J Clin Oncol2014;13:476-82

[95] Hodgkinson CL,Li Y,Rothwell DG,Polanski R,Simpson KL,Pepper SD,Greystoke A,Bola B,Antonello J,Faulkner S,Carter L,Miller CJ,Brady G.Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer..Nat Med2014;20:897-903

[96] Punnoose EA,Liu W,Fine BM,Hicks RJ,Amler LC,Lackner MR.Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib..Clin Cancer Res2012;18:2391-401

[97] Hofman V,Long E,Selva E,Mograbi B,Vénissac N,Milano G,Marquette CH,Hofman P.Detection of circulating tumor cells from lung cancer patients in the era of targeted therapy: promises, drawbacks and pitfalls..Curr Mol Med2014;14:440-56

[98] Boshuizen R,van den Heuvel M.Circulating tumor cells in non-small cell lung carcinoma..J Thorac Dis2012;4:456-8

[99] Maheswaran S,Nagrath S,Brannigan B,Inserra E,Iafrate AJ,Digumarthy S,Irimia D,Tompkins RG,Toner M.Detection of mutations in EGFR in circulating lung-cancer cells..N Engl J Med2008;359:366-77 PMCID:PMC3551471

[100] Nel I,Gauler T.Individual profiling of circulating tumor cell composition in patients with non-small cell lung cancer receiving platinum based treatment..Transl Lung Cancer Res2014;3:100-6

[101] Tanaka F,Hasegawa S.Circulating tumor cells (CTCs) in lung cancer: Current status and future perspectives..Lung Cancer Targets Ther2010;1:77-84

[102] Cheng M,Yang HS.Circulating tumor cells are associated with bone metastasis of lung cancer..Asian Pac J Cancer Prev2014;15:6369-74

[103] Hou JM,Ward T,Sloane R,Dive C.Circulating tumor cells, enumeration and beyond..Cancers (Basel)2010;2:1236-50 PMCID:PMC3835128

[104] Krebs MG,Priest L,Hou JM,Ward TH,Hughes A,Ranson M,Blackhall FH.Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer..J Clin Oncol2011;29:1556-63

[105] Ilie M,Long-Mira E,Vignaud JM,Mouroux J,Hofman P.''Sentinel'' circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease..PLoS One2014;9:e111597

[106] Yang SH.Circulating tumor cells in lung cancer..J Lung Cancer2011;10:13-25

[107] Wong MP.Circulating tumor cells as lung cancer biomarkers..J Thorac Dis2012;4:631-4

[108] Olmedo ME,Earl J,Santon A,Vallejo C,Gorospe L,Gordoa TA,Roberts E,Gortez P,Muñoz J,Garrido P.Monitoring circulating tumor cells (CTC) in lung cancer: preliminary results..Ann Oncol2014;25:iv83

[109] Sullivan JP1,Madden MW,Springer S,Chi AS,Rothenberg SM,Kapur R,Iafrate AJ,Loeffler JS,Louis DN,Maheswaran S.Brain tumor cells in circulation are enriched for mesenchymal gene expression..Cancer Discov2014;4:1299-309 PMCID:PMC4221467

[110] Sullivan JP,Chi AS,Oliveira SM,Wakimoto H,Shah K,Shah AM,Toner M,Haber DA.Molecular characterization of circulating glioblastoma cells indentifies a mescenchymal-like tumour cell subpolulation..Cancer Res2014;74:4004

[111] Grisanti S,Consoli F,Verardi R,Bianchetti A,Mangoni M,Biti G,Ferrari VD,Magrini SM.Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: Prognostic and predictive significance..PLoS One2014;9:e103918

[112] Zhou YM,Li B,Sui CJ,Yang JM.Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma..Ann Surg Oncol2012;19:1700-6

[113] Nezos A,Lembessis P,Dimopoulos P,Tzelepis K.Detection of circulating tumor cells in bladder cancer patients..Cancer Treat Rev2009;35:272-9

[114] Msaouel P.Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis..BMC Cancer2011;11:336 PMCID:PMC3161042

[115] Ju M,Steinmetz D,Keefe SM,Christodouleas JP,Dorsey JF.Application of a telomerase-based circulating tumour cell (CTC) assay in bladder cancer patients receiving postoperstive radiation therapy: a case study..Cancer Biol Ther2014;15:683-7 PMCID:PMC4049784

[116] Häfner N,Altgassen C,Greinke C,Schneider A.HPV16-E6 mRNA is superior to cytokeratin 19 mRNA as a molecular marker for the detection of disseminated tumour cells in sentinel lymph nodes of patients with cervical cancer by quantitative reverse-transcription PCR..Int J Cancer2007;120:1842-6

[117] Sheng W,Chen T,George TJ,Fan ZH.Capture, release and culture of circulating tumour cells from pancreatic cancer patients using an enhanced mixing chip..Lab Chip2014;14:89-98 PMCID:PMC3918168

[118] de Albuquerque A,Breier G,Fersis N,Kaul S.Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study..Oncology2012;82:3-10

[119] Ankeny JS,Lin M,Song M,Girgis MD,Wainberg ZA,Tomlinson JS.Pancreatic circulating tumor cells as a diagnostic adjunct in pancreatic cancer..J Clin Oncol2014;32:abstr175

[120] Kuhlmann JD,Bankfalvi A,Schöler S,Buderath P,Otterbach F,Kasimir-Bauer S.ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum resistance..Clin Chem2014;60:1282-9

[121] Obermayr E,Pils D,Braicu I,Mahner S,Vergote I.Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance - a study of the OVCAD consortium..Gynecol Oncol2013;128:15-21

[122] Kim JH,Jeong MS,Kang KW.One-step detection of circulating tumor cells in ovarian cancer using enhanced fluorescent silica nanoparticles..Int J Nanomedicine2013;8:2247-57